Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

Complex hmo blend stoichiometry: NestleRecent Research Landscape

Infant gut dysbiosis leads to poor developmental outcomes and immune system failure. Precise titration of human milk oligosaccharide structures triggers targeted butyrate production to accelerate microbiome maturation.

What technical problems is Nestle addressing in Complex hmo blend stoichiometry?

Infant intestinal microbiota dysbiosis

(32)evidences

Imbalanced gut bacterial populations lead to increased susceptibility to non-rotavirus diarrhea and poor metabolic health. Restoring microbial equilibrium improves host immune defense and nutrient absorption.

Neonatal gastrointestinal immaturity

(5)evidences

Life-threatening gastrointestinal tissue death and systemic inflammation in vulnerable neonates. Mitigating this pathology reduces infant mortality and long-term developmental morbidity.